Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer
Tesa Severson(The Netherlands Cancer Institute), Andries M. Bergman(Oncode Institute)
Cited by 7
Related Papers
Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)
|Drug Resistance Updates|2002|353